ArticleGastroenterology2014

FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.

Poonam Mishra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.